Publications by authors named "Steven Hubert"

Claim this Profile
D
Development of a Modified-Release Formulation of Lovastatin Targeted to Intestinal Methanogens Implicated in Irritable Bowel Syndrome With Constipation.
Steven Hubert, Alan Chadwick, Vince Wacher, Olivia Coughlin, John Kokai-Kun

J Pharm Sci· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation development of SYN-004 (ribaxamase) oral solid dosage form, a β-lactamase to prevent intravenous antibiotic-associated dysbiosis of the colon.
Andrew Bristol, Steven Hubert, Felix Hofmann, Hans Baer

Int J Pharm· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection.
Michael Kaleko, J Andrew Bristol, Steven Hubert, Todd Parsley, Giovanni Widmer

Anaerobe· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies.
Tracey Roberts, John F Kokai-Kun, Olivia Coughlin, Barbara Valero Lopez, Heidi Whalen, Steven Hubert

Clin Drug Investig· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis